We suggest that such a decrease in the concentration of adiponectin in tissues may occur as a result of the competitive displacement of adiponectin from the T-cadherin receptor by LDL in cases of dyslipidemia. The gene discussed is ADIPOQ; the disease is metabolic syndrome.